Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes
Authors:
- Keiichi KarasawaKKKeiichi Karasawa
- Kohei HironakaKHKohei Hironaka
- Kohei TaharaKTKohei Tahara
- Yuichi TozukaYTYuichi Tozuka
- Hirofumi TakeuchiHTHirofumi Takeuchi
- 1 April 2013
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 83 (3) , 364-369
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Edaravone-Loaded Liposome Eyedrops Protect against Light-Induced Retinal Damage in MiceInvestigative Ophthalmology & Visual Science, 2011
- Hybrid-modified poly(d,l-lactide-co-glycolide) nanospheres for a novel cellular drug delivery systemInternational Journal of Pharmaceutics, 2010
- Physicochemical Properties Affecting Retinal Drug/Coumarin-6 Delivery from Nanocarrier Systems via Eyedrop AdministrationInvestigative Ophthalmology & Visual Science, 2010
- Ocular Drug DeliveryThe AAPS Journal, 2010
- Design and evaluation of a liposomal delivery system targeting the posterior segment of the eyeJournal of Controlled Release, 2009
- Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cellsExperimental Eye Research, 2009
- FIRST VERSUS SECOND EYE INTRAVITREAL RANIBIZUMAB THERAPY FOR WET AMDRetina, 2009
- Niosome-Encapsulated Gentamicin for Ophthalmic Controlled DeliveryAAPS PharmSciTech, 2008
- Acyclovir-containing liposomes for potential ocular deliveryJournal of Controlled Release, 2000
- Polycation-induced enhancement of epithelial paracellular permeability is independent of tight junctional characteristicsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993